bullish
Venus MedTech Vs MicroPort CardioFlow
241 Views22 Mar 2021 09:16
This article analyzed the difference between MicroPort CardioFlow and Venus Medtech in terms of sales performance, product progress, industry characteristics, and the gap in their market value.
SUMMARY
(Sign Up to Access)Get started on the Smartkarma Research Network with a complimentary Preview Pass to:
- Unlock all research summaries
- Follow top, independent analysts
- Receive personalised alerts and emails
- Access Briefings, Analytics, and Events
Upgrade anytime to our paid plans for full-length research, real-time analyst discussions, and more.
Join a thriving community of 45,000+ investors, including the top global asset managers managing over $13trn in assets.
or
Already have an account? Sign In Now
Full Insight
(Paid Plans Only, 3-minute read)
Discussions
(Paid Plans Only)
Top 5%
Xinyao (Criss) Wang
HK/China Healthcare Analyst (ex-Fosun Pharma)
Price Chart(Sign Up to Access)
- Tinavi Medical Technologies (688277.CH) - Time Is Running Out for Tinavi10 Jun 2021
- Antengene (6996.HK) - Still Has a Long Way to Go Despite the New Progress On Selinexor20 May 2021
- Microport Scientific (853.HK) - It Is a Good Time to See Some Concerns17 May 2021
- Venus MedTech Vs MicroPort CardioFlow22 Mar 2021
- CanSino Biologics (6185.HK) - Will the COVID-19 Vaccine Be the Turning Point?03 Mar 2021
- Pre-IPO BeiGene - Would the IPO on the STAR Market Be the Last Hurrah?03 Feb 2021
- Pre-IPO MicroPort CardioFlow - A Better Candidate of the TAVR Market in China?16 Dec 2020
x